Vitamin D3 + K2 Dosage, half-life & reference guide
Also known as Vitamin D3 · Vitamin D · Cholecalciferol · D3 · Vitamin K2 · MK-7 · Menaquinone-7 · D3/K2 · D3 K2
Reviewed Evidence: EstablishedPublished by PepVault
Vitamin D3, the sunshine vitamin, paired with vitamin K2, which helps direct calcium into bone. Large trials of 2,000 IU of D3 a day in mostly healthy older adults found no fewer cancers, heart attacks, fractures or deaths, though autoimmune disease was about a fifth less common. K2 slowed bone loss and artery stiffening in a 3-year trial in older women.
- Studied range
- 1000–2000 IU
- How often
- Daily
- Evidence
- ●●●
Established - Routes
- Oral capsule, Oral drops
Studied in research — not a recommendation.
How it works.
Vitamin D3 is the form the skin makes in sunlight; the body turns it into the hormone that controls calcium absorption and acts on bone, muscle and immune cells. Vitamin K2 (menaquinone-7) switches on proteins that put calcium into bone (osteocalcin) and keep it out of artery walls (matrix Gla protein). The idea of pairing them is that D raises calcium uptake and K2 steers it. The large trials tested D3 on its own in people who were mostly not deficient: it did not prevent cancer, heart disease, fractures or death, though autoimmune disease was less common. K2 has smaller trials of bone loss and artery stiffness. The pair together has no outcome trial.
Commonly reported: Nothing felt; people take it because a blood test shows low vitamin D, or for the long game.
Your report
Taken Vitamin D3 + K2? What did you notice?
One tap to start. About 30 seconds, no account.

Week by week.
What to expect in the first 8 weeks
- Onset
- About 3 months for blood vitamin D to rise to a new level
- Peak effect
- Not felt; measured by a 25(OH)D blood test
- Duration
- Ongoing; the big trials ran 3–5 years
Day 1–90RCT
A blood test shows it, not a feeling
Vitamin D works slowly and silently: the blood level climbs over the first few months of daily use. A 25(OH)D test is how people see where they started and where they landed.
The science
Burt 2019: in 311 adults aged 55–70 starting near 78–81 nmol/L, 25(OH)D at 3 months was 115 nmol/L on 4,000 IU and 188 on 10,000 IU a day, against 77 on 400 IU. In D-Health, 60,000 IU monthly gave 115 vs 77 nmol/L on placebo.
Sources- Burt et al. (2019)
- Neale et al. (D-Health) (2022)
Updated Nov 2026
Any dayRCT
What vitamin D3 + K2 is built on
Vitamin D has the strongest trial record of any supplement here, and mostly null results in people who were not deficient. More is not better: above 4,000 IU a day, bone density fell slightly more than at a low dose. K2 rests on smaller trials, and the pairing itself has no outcome trial.
The science
Burt 2019 (JAMA): 3 years at 400, 4,000 or 10,000 IU a day; radial volumetric BMD −1.2%, −2.4% and −3.5%. EFSA UL overview (v11, Aug 2025): vitamin D 100 mcg (4,000 IU) a day for adults; vitamin K no UL. DO-HEALTH (post hoc, 777 adults, 3 years): vitamin D with omega-3 and exercise had an additive effect on one epigenetic clock (PhenoAge), of a few months (Bischoff-Ferrari 2025). Not tested by the NIA ITP.
Sources- Burt et al. (2019)
- EFSA NDA Panel (UL overview) (2025)
- Bischoff-Ferrari et al. (DO-HEALTH) (2025)
Updated Nov 2026
With Omega-3 (EPA/DHA)RCT
With omega-3 and exercise
In a 3-year trial in older Europeans, vitamin D, omega-3 and home exercise each nudged one measure of biological age, and together the effect added up to a few months. A small effect, measured by blood clocks rather than health events.
The science
Bischoff-Ferrari 2025 (Nat Aging, DO-HEALTH, post hoc, 777 participants): 2,000 IU vitamin D, 1 g omega-3 and/or a home exercise program for 3 years; omega-3 alone slowed PhenoAge, GrimAge2 and DunedinPACE; the three had additive benefits on PhenoAge; standardized effects 0.16–0.32 units (2.9–3.8 months).
Sources- Bischoff-Ferrari et al. (DO-HEALTH) (2025)
Updated Nov 2026
After week 8
Day 90–365RCT
K2 and where calcium goes
K2 activates the proteins that build calcium into bone and keep it out of arteries. In a 3-year trial in older women, 180 mcg of MK-7 a day slowed bone loss at the spine and hip and eased artery stiffness, against placebo.
The science
Knapen 2013: 244 healthy postmenopausal women, MK-7 180 mcg a day or placebo for 3 years; better vitamin K status and less age-related decline in BMC and BMD at the lumbar spine and femoral neck (not total hip), with better bone strength. Knapen 2015: in the same women, carotid-femoral pulse wave velocity and the stiffness index fell, and dp-ucMGP (inactive matrix Gla protein) fell by 50%.
Sources- Knapen et al. (2013)
- Knapen et al. (2015)
Updated Nov 2026
Day 365+RCT
What five years of vitamin D showed
In two of the largest supplement trials ever run, vitamin D in mostly healthy older adults did not prevent cancer, heart disease, fractures or early death. One outcome did move: confirmed autoimmune disease was about a fifth less common.
The science
VITAL (25,871 US adults, 2,000 IU a day, median 5.3 years): invasive cancer HR 0.96 (0.88–1.06), major cardiovascular events HR 0.97 (0.85–1.12) (Manson 2019); total fractures HR 0.98 (LeBoff 2022); autoimmune disease HR 0.78 (0.61–0.99) (Hahn 2022). D-Health (21,315 Australians over 60, 60,000 IU monthly, 5 years): all-cause mortality HR 1.04 (0.93–1.18) (Neale 2022). Participants were not selected for deficiency.
Sources- Manson et al. (VITAL) (2019)
- LeBoff et al. (2022)
- Hahn et al. (2022)
- Neale et al. (D-Health) (2022)
Updated Nov 2026
Day 1 is the day you start it.
Large randomized trials of vitamin D3 (VITAL, D-Health), a 3-year dose trial, two 3-year MK-7 trials, EFSA's upper levels and the warfarin label. No outcome trial of the D3 + K2 combination.
Clinical trial data
A typical run.
Run notes
- Cycle
- Taken daily; some take vitamin D as a weekly or monthly dose (D-Health gave 60,000 IU once a month). The big trials ran 3–5 years.Community practice — opinions vary. Not a clinical recommendation.
- Timing
- Both are fat-soluble, so many take them with a meal that has some fat. Vitamin D is dosed in IU (1 mcg = 40 IU); K2 in mcg (the bone and artery trials used 180 mcg of MK-7 a day).
- Routes
- Oral capsule, Oral drops
- Stacks
- Magnesium, Omega-3 (EPA/DHA), Creatine
Safety.
Common side effects
- No common side effects at the trial doses
- High blood calcium with far too much vitamin D (rare; toxicity)
Interactions
Warfarin is a vitamin K antagonist: its label says more vitamin K lowers its effect and asks for a steady vitamin K intake, and in a study as little as 10 mcg of MK-7 a day lowered the INR in at least 40% of volunteers on a similar drug. Discuss every medication with your clinician.
Safety notes
Vitamins sold as supplements. EFSA sets the upper level for vitamin D at 100 mcg (4,000 IU) a day for adults; there is no upper level for vitamin K. Above that level, a 3-year Canadian trial found bone density fell slightly more at 4,000 and 10,000 IU a day than at 400 IU. Vitamin D toxicity, rare and mostly from far too much, raises blood calcium and can harm the kidneys. Vitamin K matters most for anyone on warfarin or a similar blood thinner: even 10–20 mcg a day of MK-7 shifted the INR in volunteers, so K2 is started, stopped or changed only with the prescriber. Discuss with your clinician.
Goes with.
One question at a time.
Questions people ask.
What is Vitamin D3 + K2?
Vitamin D3, the sunshine vitamin, paired with vitamin K2, which helps direct calcium into bone. Large trials of 2,000 IU of D3 a day in mostly healthy older adults found no fewer cancers, heart attacks, fractures or deaths, though autoimmune disease was about a fifth less common. K2 slowed bone loss and artery stiffening in a 3-year trial in older women.
How is Vitamin D3 + K2 dosed in research?
The research range for Vitamin D3 + K2 is 1000–2000 IU, daily. Studied in research — not a recommendation.
How long does Vitamin D3 + K2 last?
The half-life of Vitamin D3 + K2 is not a single number: blood 25(OH)D, the measured form of vitamin D, rises over the first months of daily use (Burt 2019); MK-7 lasts longer in blood than vitamin K1 (Knapen 2013).
What do people report on Vitamin D3 + K2?
Commonly reported on Vitamin D3 + K2: nothing felt; people take it because a blood test shows low vitamin D, or for the long game.
Is Vitamin D3 + K2 safe?
The research basis for Vitamin D3 + K2 is established: clinical trials or FDA-approved use exists. Common side effects in the library: no common side effects at the trial doses and high blood calcium with far too much vitamin D (rare; toxicity).
What does Vitamin D3 + K2 stack with?
Common stacks for Vitamin D3 + K2: Magnesium, Omega-3 (EPA/DHA) and Creatine.
Research.
Reference.
- Cadence
Daily
- Half-life
Not a single number: blood 25(OH)D, the measured form of vitamin D, rises over the first months of daily use (Burt 2019); MK-7 lasts longer in blood than vitamin K1 (Knapen 2013)
- Research basis
●●●
EstablishedClinical trials or FDA-approved use exists
Reviewed How we check the library
